rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Pril

Subscribe via RSS
Rediff.com  »  News  »   Pril

  News for Pril

  • Business

Rangebound markets end flat

 Markets ended flat amid a range bound trading session on Monday as investors booked profits in index heavyweights and shifted focus to the broader markets.The Sensex ended higher by 17 points or......

Pantaloon plans to invest Rs 250 cr

Kishore Biyani-led Pantaloon Retail India (PRIL) will invest close to Rs 250 crore (Rs 2.5 billion) within the next year-and-half for setting up 10 Central malls in the country. With this, India's......

Manpower dearth may trip Pantaloon: Report

 Pantaloon Retail India Ltd has set lofty growth targets for itself, but execution of these targets may be jeopardised by a shortage of manpower, a research report issued by Deutsche Bank AG......

A food fiesta in malls

 There's something about shopping at malls that is hunger inducing. Little wonder all malls have food counters and they do the briskest business. It's this insight into consumer behaviour that is......

Lupin plant to manufacture Lisinopril

 Lupin Ltd commissioned its facility at Mandideep near Bhopal, Madhya Pradesh, to manufacture Lisinopril, an active pharmaceutical ingredient in the cardiovascutar segment with a capacity of 12MT......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2025 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances